Irritable Bowel Syndrome Trial, Recruiting NCT07176078 Sponsor: Universitair Ziekenhuis Brussel Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT07176078
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with Irritable Bowel Syndrome (IBS) by a doctor using a standard set of diagnostic guidelines, and whose IBS symptoms are rated as moderate to severe on a recognised symptom scoring scale
  • People who have been diagnosed with fibromyalgia (a condition causing widespread, long-term pain) by a doctor, or who meet a specific set of recognised criteria for fibromyalgia involving pain lasting at least 3 months across multiple areas of the body, measured by standard scoring tools (confirm with trial site)
  • People who use probiotic products or follow a low-lactose diet may still be eligible, as long as their intake stays consistent throughout the study
  • People who take IBS-related medications, including antidepressants, may still be eligible if the dose has been stable for at least 2 to 3 months before joining
  • People who are willing to make some adjustments to their usual eating habits during the study

Who may not be able to join:

  • People who have other digestive or gut conditions (such as inflammatory bowel disease or coeliac disease) that could explain their current symptoms
  • People who have conditions that affect how the gut works, or who have had weight-loss (bariatric) surgery in the past
  • People who have allergies or sensitivities to foods, other than lactose intolerance
  • People who have significant dietary restrictions or food allergies
  • People who are pregnant or planning to become pregnant within the next seven months
  • People whose body weight falls into a very low range based on standard height-and-weight measurements (BMI of 18 or below)
  • People who are already receiving osteopathic treatment for IBS, or who are already following the low-FODMAP diet

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +32-2-629.27.17

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universitair Ziekenhuis Brussel
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
1 December 2026

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Change in Irritable Bowel Syndrome Symptom Severity Score (IBS-SSS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov